References

Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension

10.1016/j.jacc.2021.01.014 · 2021 · External reference

Blood pressure and its variability: classic and novel measurement techniques

10.1038/s41569-022-00690-0 · 2022 · External reference

Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension

10.1161/jaha.117.007131 · 2017 · External reference

Blood pressure time at target and its prognostic value for cardiovascular outcomes: a scoping review

10.1038/s41440-024-01798-1 · 2024 · External reference

Time in target range for blood pressure and adverse health outcomes: a systematic review

10.1161/hypertensionaha.124.24013 · 2025 · External reference

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

10.1056/nejmoa1805819 · 2018 · External reference

Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial

10.1093/eurheartj/ehaf514 · 2025 · External reference

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial

10.1016/j.cct.2013.09.014 · 2013 · External reference

Health characteristics and aspirin use in participants at the baseline of the ASPirin in Reducing Events in the Elderly - eXTension (ASPREE-XT) observational study

10.1016/j.cct.2023.107231 · 2023 · External reference

Recommendations for blood pressure measurement in humans and experimental animals, part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council

10.1161/01.hyp.0000150859.47929.8e · 2005 · External reference

A method to determine the optimal intensity of oral anticoagulant therapy

10.1055/s-0038-1651587 · 1993 · External reference

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

10.1016/s0140-6736(02)11911-8 · 2002 · External reference

The effect of low-dose aspirin on frailty phenotype and frailty index in community-dwelling older adults in the ASPirin in Reducing Events in the Elderly Study

10.1093/gerona/glab340 · 2022 · External reference

Blood pressure time in target range and its impact on clinical outcomes

10.1007/s11886-024-02111-9 · 2024 · External reference

Systolic blood pressure time in target range and major adverse kidney and cardiovascular events

10.1161/hypertensionaha.122.20141 · 2023 · External reference

Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT trial

10.1161/hypertensionaha.123.21651 · 2023 · External reference

Systolic blood pressure time in target range and acute kidney injury in patients with hypertension

10.1161/hypertensionaha.125.25511 · 2025 · External reference

Systolic blood pressure time in target range and cognitive outcomes: insights from the SPRINT MIND trial

10.1161/hypertensionaha.122.20711 · 2023 · External reference

Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: an observational analysis of ALLHAT

10.1111/jch.13515 · 2019 · External reference

Association of systolic blood pressure time in target range with cardiovascular events among PRECISION participants

10.1111/jch.70009 · 2025 · External reference

Time spent at blood pressure target and the risk of death and cardiovascular diseases

10.1371/journal.pone.0202359 · 2018 · External reference

Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study

10.1093/eurjpc/zwad083 · 2023 · External reference

Optimizing blood pressure targets in patients with cardiovascular disease: rethinking control in terms of time in range

2026 · External reference